Hemorrhagic Fever
Filter
37
Featured
Language
Document type
No document type
27
Infographics
6
Online Courses
3
Guidelines
1
Countries / Regions
Congo, Democratic Republic of
10
Guinea
8
Burkina Faso
8
Mali
7
Côte d’Ivoire / Ivory Coast
7
Sierra Leone
6
Liberia
6
Senegal
6
Nigeria
4
Niger
3
Rwanda
3
West and Central Africa
2
Guinea-Bissau
1
Cameroon
1
Uganda
1
Ethiopia
1
Togo
1
Chad
1
Ghana
1
Authors & Publishers
World Health Organization WHO
10
World Health Organization
7
Organisation Mondiale de la Santé OMS
6
World Health Organization, Regional Office for Africa
2
World Health Organization (WHO)
2
Centers of Disease Control CDC
2
World Food Programme
2
Ministry of Health, Democratic Republic of Congo
2
UNICEF
2
Pierre Aubry
1
Baert, B.
1
CDC
1
MSF
1
European Network for Diagnostics of Imported Viral Diseases
1
Centers of Disease Controle CDC
1
Centers for Disease Control and Prevention , World Health Organization WHO
1
Centers for Disease Control and Prevention , WHO
1
Organisation mondiale de la Santé (OMS)
1
Publication Years
Category
Hemorrhagic Fever
37
Online Courses & Platforms
3
Paediatrics
2
Clinical Training
2
Under-5 nutrition
2
Pediatrics
2
Disease Prevention & Control
2
Infection Control & Prevention (IPC)
1
Mobile Training Tools & Apps
1
Reproductive Health
1
Toolboxes
Treatment Guidelines
17
Infection Control
9
Pediatrics
6
Poster
6
Preparedness & Prevention
5
Ebola Prevention & Control
4
Context, Facts & Travel Advice
2
Social Mobilisation
2
Training
2
Ebola
2
IPC
2
Manual & Leaflet
2
Public Health
1
Clinical Guidelines
1
Roadmaps, Action Plans & Policies
1
Clinical Guidelines
1
Training Material
1
Research
1
Public Health
1
WASH
1
Key Resources
1
e-Learning
1
Guide de poche pour l’agent de santé en première ligne Ce guide s’intéresse plus particulièrement à certaines fièvres hémorragiques virales (FHV) Ebola, Marburg, FHCC, fièvre de Lassa [et Lujo] – qui surviennent en Afrique et risquent de donner lieu à une transmission interhumaine. I... more
Interim Guidance.
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ... more
The purpose of this pocketbook is to provide clear guidance on current best management practices for VHF across health-care facilities
La fièvre de Lassa est une fièvre hémorragique virale aiguë d'une durée d'une à quatre semaines qui sévit en Afrique occidentale. La fièvre de Lassa, une fièvre hémorragique virale avec des symptômes similaires à ceux de la maladie virale d'Ebola, est endémique dans une grande partie de... more
Ce document présente des recommandations sur les soins cliniques et le dépistage du virus chez les survivants de la maladie à virus Ebola. Il s'adresse principalement aux professionnels de santé qui dispensent des soins primaires aux personnes ayant survécu.
Table des matières
... more
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level. The aim of the document is to assist Member States and releva... more
This comprehensive intermediate level course is for clinicians caring for patients with suspected or confirmed Ebola virus disease (EVD). Modules provide information on screening and triage, infection prevention and control, laboratory diagnostics, organization of the Ebola Treatment Centre (ETC), c... more
To save the lives of mothers and their babies, mitigate complications, and limit the spread of disease, it is critical that recommendations are made on the prevention, treatment, and surveillance of women who are exposed to EVD, acquire EVD during pregnancy or breastfeeding, or survive EVD with ongo... more
Guidance for health care workers. Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers. Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers. Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers. Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.